Table 3.

Biochemical parameters before and after treatment completion (measured at day 5 or discharge, whichever is earlier). Values are represented as Mean ± SD (95% Confidence Interval).

Parameters		Study Group (n = 42)	Control Group (n = 43)	p-value
Plasma pseudocholinesterase (expressed in kIU/L) [Normal: 8-18 kIU/L] [18]	At admission	2.74 ± 1.19 (2.37–3.11)	2.46 ± 1.07 (2.13–2.80)	0.26
	After treatment completion	7.27 ± 3.31 (6.24–8.30)	7.37 ± 2.94 (6.46–8.27)	0.89
Plasma total Malonaldehyde (MDA)	At admission	4.69 ± 4.91 (3.15–6.22)	4.56 ± 4.82 (3.08–6.05)	0.91
(expressed in μmol/L) [19,20]	After treatment completion	5.00 ± 5.94 (3.15–6.85)	4.31 ± 4.00 (3.08–5.55)	0.53
Free reduced Glutathione (GSH) level in plasma	At admission	3.47 ± 1.12 (3.12–3.81)	3.28 ± 1.15 (3.18–3.90)	0.75
(expressed in μmol/L) [Normal: 3.39 ± 1.04 μmol/L] [21]	After treatment completion	4.33 ± 1.52 (3.87–4.79)	4.04 ± 1.56 (3.55–4.52)	0.38
Serum Magnesium levels (expressed in mg/dL) [Normal: 1.8–2.29 mg/dL] [22]	At admission	1.64 ± 0.47 (1.50–1.78)	1.50 ± 0.61 (1.31–1.69)	0.32
	After treatment completion	3.34 ± 1.57 (2.88–3.81)	2.97 ± 1.57 (2.48–3.46)	0.27